Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMRS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $139,296
Award facts
- Contract value 100% obligated
- $139,295.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $139,296 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group's PPV-G GEN V IDC, valued at $499,999,999 and effective through December 31, 2036, authorizes the DLA to issue delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations worldwide. The contractor's extensive product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals. As one of multiple regional prime vendor contractors under the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group has established itself as a critical pharmaceutical supplier within the federal military medical supply chain, with no identified subcontractors on this award.
Quick answers
Who was awarded contract SPE2DU26FEMRS?
SPE2DU26FEMRS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DU26FEMRS worth?
The government has obligated $139,296 on SPE2DU26FEMRS.
Is contract SPE2DU26FEMRS an order under another contract?
Yes. SPE2DU26FEMRS is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMRS competed?
The extent of competition for SPE2DU26FEMRS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award